Cheminfomatic-based Drug Discovery of Human Tyrosine Kinase Inhibitors

Publisher： Bentham Science Publishers

E-ISSN： 1873-4294|16|13|1452-1462

ISSN： 1568-0266

Source： Current Topics in Medicinal Chemistry, Vol.16, Iss.13, 2016-05, pp. : 1452-1462

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Ligand-based receptor tyrosine kinase partial agonists: new paradigm for cancer drug discovery?

By Riese David J  

Expert Opinion on Drug Discovery, Vol. 6, Iss. 2, 2011-02 ,pp. : 185-193

Informa Healthcare

Access to resources Recommend Favorite

Fragment-Based Discovery of Inhibitors of Protein Kinase B

By  

Current Topics in Medicinal Chemistry, Vol. 9, Iss. 18, 2009-12 ,pp. : 1705-1717

Bentham Science Publishers

Access to resources Recommend Favorite

Selective tyrosine kinase inhibitors

By Wilkinson S.E.   Harris W.  

Expert Opinion on Emerging Drugs, Vol. 5, Iss. 3, 2000-10 ,pp. : 287-297

Informa Healthcare

Access to resources Recommend Favorite

Tyrosine Kinase Inhibitors

By  

Current Cancer Drug Targets, Vol. 10, Iss. 5, 2010-08 ,pp. : 462-483

Bentham Science Publishers

Access to resources Recommend Favorite

Structure-based Drugs Design Studies on Spleen Tyrosine Kinase Inhibitors

By  

Letters in Drug Design & Discovery, Vol. 13, Iss. 9, 2016-11 ,pp. : 845-858

Bentham Science Publishers

Access to resources Recommend Favorite